Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

· finance.yahoo.com

It's not much of a rivalry yet.

Demand for GLP-1 drugs is soaring. Thanks to recent breakthroughs, medicines in this category are expanding their addressable markets and treating conditions su...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI